Corpus Intelligence IC Memo — BRONSON METHODIST HOSPITAL 2026-04-26 11:18 UTC
IC Memo — BRONSON METHODIST HOSPITAL
Investment Committee Memorandum | MI | 439 beds | Grade B | EBITDA uplift $78.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRONSON METHODIST HOSPITAL

CCN 230017 | nan, MI | 439 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

BRONSON METHODIST HOSPITAL is a 439-bed suburban community hospital in nan, MI with $1.06B in net patient revenue and a -1.4% operating margin. The hospital serves a payer mix of 16.6% Medicare, 4.6% Medicaid, and 78.9% commercial.

Thesis: Undervalued. Our ML models identify $78.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.4% to 5.9% (+736bps).

Net Revenue HCRIS$1.06B
Current EBITDA COMPUTED$-15.2M
Operating Margin COMPUTED-1.4%
Occupancy HCRIS78.1%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS38.6%
Distress Probability ML41.6%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
30
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -1.4% places it above the state median. Among 30 size-comparable peers (220-878 beds), the median margin is -7.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (220-878), prioritizing same-state peers. 30 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRONSON METHODIST HOSPITAL (Target)MI439$1.06B-1.4%
HENRY FORD HOSPITALMI670$2.32B-14.8%
TRINITY HEALTH ANN ARBORMI475$1.00B-1.0%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%
ASCENSION PROVIDENCE HOSPITALMI527$849.3M-6.5%
WILLIAM BEAUMONT HOSPITAL - TRMI484$747.4M2.3%
MUNSON MEDICAL CENTERMI401$710.9M-7.0%
W.A. FOOTE MEMORIAL HOSPITALMI331$681.8M-9.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $78.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$22.3M+210bp18mo
Cost to Collect4.5%2.5%$21.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$21.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$12.9M+122bp9mo
Clean Claim Rate88.0%96.0%$681K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$22.3M
Cost to Collect
$21.3M
Denial Rate Reduction
$21.1M
A/R Days Reduction
$12.9M
Clean Claim Rate
$681K
Total EBITDA Uplift$78.3M
Current EBITDA$-15.2M
+ RCM Uplift+$78.3M
Pro Forma EBITDA$63.1M
Current Margin-1.4%
Pro Forma Margin5.9%
WC Released (1x)$40.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-23.4M$682.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-23.4M$743.1M0.00x-100.0%
Bull Case9.0x11.0x$-21.1M$993.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-21.1M$1.08B0.00x-100.0%
Bear Case11.0x10.0x$-25.8M$298.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-25.8M$320.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 30 hospitals with 220-878 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-12.8% / P50=-7.1% / P75=-3.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.